BioCryst Pharmaceuticals
BCRX
#5073
Rank
โ‚ฌ1.37 B
Marketcap
6,52ย โ‚ฌ
Share price
-3.07%
Change (1 day)
-9.49%
Change (1 year)

Market capitalization of BioCryst Pharmaceuticals (BCRX)

Market cap: โ‚ฌ1.37 Billion

As of December 2025 BioCryst Pharmaceuticals has a market cap of โ‚ฌ1.37 Billion. This makes BioCryst Pharmaceuticals the world's 5073th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioCryst Pharmaceuticals from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ1.37 B-10.56%
2024โ‚ฌ1.53 B38.29%
2023โ‚ฌ1.10 B-44.38%
2022โ‚ฌ1.99 B-9.33%
2021โ‚ฌ2.20 B105.76%
2020โ‚ฌ1.06 B125.37%
2019โ‚ฌ0.47 B-38.88%
2018โ‚ฌ0.77 B92.81%
2017โ‚ฌ0.40 B-9.28%
2016โ‚ฌ0.44 B-35.89%
2015โ‚ฌ0.69 B-3.76%
2014โ‚ฌ0.71 B121.23%
2013โ‚ฌ0.32 B495.23%
2012โ‚ฌ54.63 M-36.47%
2011โ‚ฌ85.99 M-50.79%
2010โ‚ฌ0.17 B-11.73%
2009โ‚ฌ0.19 B428.05%
2008โ‚ฌ37.49 M-76.67%
2007โ‚ฌ0.16 B-37.29%
2006โ‚ฌ0.25 B-37.1%
2005โ‚ฌ0.40 B339.45%
2004โ‚ฌ92.71 M-4.65%
2003โ‚ฌ97.23 M499.64%
2002โ‚ฌ16.21 M-79.46%
2001โ‚ฌ78.94 M-35.98%
2000โ‚ฌ0.12 B-75.63%
1999โ‚ฌ0.50 B473.52%
1998โ‚ฌ88.24 M8.26%
1997โ‚ฌ81.51 M-56.88%
1996โ‚ฌ0.18 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of BioCryst Pharmaceuticals was reported to be:

โ‚ฌ1.37 Billion
by Nasdaq info icon info icon
โ‚ฌ1.37 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Repligen
RGEN
โ‚ฌ7.97 B 481.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ2.00 B 45.97%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚ฌ19.01 M-98.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚ฌ0.96 B-29.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ129.18 B 9,312.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚ฌ1.68 B 22.46%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ83.93 B 6,014.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
โ‚ฌ0.54 B-60.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚ฌ44.28 M-96.77%๐Ÿ‡บ๐Ÿ‡ธ USA